Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 34 citing Passarelli: Advanced glycation end product precursors impair ABCA1-dependent cholesterol.... (0.08 sec) 

ATP-binding cassette transporter A1: a cell cholesterol exporter that protects …

- physiology.org
JF Oram, JW Heinecke - Physiological reviews, 2005 - Am Physiological Soc
Blood high-density lipoprotein (HDL) levels are inversely related to risk for cardiovascular
disease, implying that factors associated with HDL metabolism are atheroprotective. One of these
factors is ATP-binding cassette transporter A1 (ABCA1), a cell membrane protein that ...
Cited by 156 - Related articles - BL Direct - All 6 versions

ATP-Binding cassette cholesterol transporters and cardiovascular disease

- ahajournals.org
JF Oram, AM Vaughan - Circulation research, 2006 - Am Heart Assoc
A hallmark of atherosclerotic cardiovascular disease (CVD) is the accumulation of cholesterol
in arterial macrophages. Factors that modulate circulating and tissue cholesterol levels have
major impacts on initiation, progression, and regression of CVD. Four members of the ...
Cited by 105 - Related articles - All 8 versions

Do glucose and lipids exert independent effects on atherosclerotic lesion initiation …

- ahajournals.org
JE Kanter, F Johansson, RC LeBoeuf, KE … - Circulation research, 2007 - Am Heart Assoc
It is becoming increasingly clear that suboptimal blood glucose control results in adverse effects
on large blood vessels, thereby accelerating atherosclerosis and cardiovascular disease, manifested
as myocardial infarction, stroke, and peripheral vascular disease. Cardiovascular disease ...
Cited by 33 - Related articles - All 8 versions

Reduction in ABCG1 in type 2 diabetic mice increases macrophage foam cell …

- jbc.org
JP Mauldin, S Srinivasan, A Mulya, A Gebre, JS … - Journal of Biological …, 2006 - ASBMB
Atherosclerosis development is accelerated severalfold in patients with Type 2 diabetes. In the
initial stages of disease, monocytes transmigrate into the subendothelial space and differentiate
into foam cells. Scavenger receptors and ATP binding cassette (ABC) Transporters play ...
Cited by 22 - Related articles - BL Direct - All 6 versions

Advanced glycation of apolipoprotein AI impairs its anti-atherogenic properties


A Hoang, AJ Murphy, MT Coughlan, MC Thomas, JM … - Diabetologia, 2007 - Springer
Abstract Aims/hypothesis AGE contribute to the pathogenesis of diabetic complications, including
dyslipidaemia and athero- sclerosis. However, the precise mechanisms remain to be
established. In the present study, we examined whether AGE modification of ...
Cited by 19 - Related articles - BL Direct - All 4 versions

Methylglyoxal induces advanced glycation end product (AGEs) formation and …

- fasebj.org
AV Cantero, M Portero-Otin, V Ayala, N Auge, M … - The FASEB Journal, 2007 - FASEB
Purpose: Low molecular weight carbonyl compounds, such as the -ketoaldehydes methylglyoxal
(MGO) and glyoxal (GO), are formed under hyperglycemic conditions and behave as advanced
glycation end product (AGE) precursors. They form adducts on proteins, thereby inducing ...
Cited by 15 - Related articles - BL Direct - All 3 versions

Cholesterol in islet dysfunction and type 2 diabetes


LR Brunham, JK Kruit, CB Verchere, MR … - The Journal of Clinical …, 2008 - pubmedcentral.nih.gov
Type 2 diabetes (T2D) frequently occurs in the context of abnormalities of plasma
lipoproteins. However, a role for elevated levels of plasma cholesterol in the pathogenesis of
this disease is not well established. Recent evidence suggests that alterations of plasma ...
Cited by 11 - Related articles - BL Direct - All 6 versions

ABCA1-dependent but apoA-I-independent cholesterol efflux mediated by fatty …


I Goldiner, AE van der Velde, KE … - Biochemical …, 2006 - pubmedcentral.nih.gov
FABACs (fatty acid–bile acid conjugates) are synthetic molecules that are designed to treat a
range of lipid disorders. The compounds prevent cholesterol gallstone formation and diet-induced
fatty liver, and increase reverse cholesterol transport in rodents. The aim of the present ...
Cited by 9 - Related articles - BL Direct - All 11 versions

Aldehyde metabolism in the cardiovascular system


D Conklin, R Prough, A Bhatanagar - Molecular BioSystems, 2007 - rsc.org
Daniel J. Conklin, PhD, was born in 1964 in Menomonie, Wisconsin. He received a BS in Biology
from the University of Wisconsin-Whitewater (1986), a MS in Biology (1989) from the University
of Wisconsin-LaCrosse, and a PhD in Biology from University of Notre Dame (1995). He ...
Cited by 8 - Related articles - Cached - BL Direct - All 3 versions

Targets for intervention in dyslipidemia in diabetes


GH Tomkin - Diabetes care, 2008 - Am Diabetes Assoc
Treatment for dyslipidemia in diabetes reduces cardiovascular events. Diabetes is associated
with major abnormalities in fatty acid metabolism. The resulting disturbance results in an abnormal
lipoprotein cascade from the large chylomicron through to the small HDL particle. This ...
Cited by 6 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google